State-by-State Clinical Trial Requirements Reference Guide 2012

  • ID: 2567602
  • Book
  • Region: United States
  • Cambridge Healthtech Institute
1 of 3
Although many clinical trial sponsors and investigators focus primarily on FDA regulations related to the conduct and design of clinical trials, their failure to comply with state laws and regulations may expose sponsors, investigators, IRBs, Institutions, or individuals to significant liability risks and call into question the potential integrity of clinical data. Today's US-based clinical trials must meet not just federal requirements, but an increasingly complex array of state specific requirements as well.

In fact, many areas critical and foundational to clinical studies – age of consent, capacity to consent, notification of state agencies, experimental drug dispensing requirements, genetic testing, and legal representatives, among many others – are driven by state, and not federal, laws. How do you monitor the requirements of all 50 states?

State-by-State Clinical Trial Requirements Reference Guide 2012 provides totally updated and expanded profiles of the clinical trial standards in all 50 states.
Note: Product cover images may vary from those shown
2 of 3
This newly updated resource breaks down each state's requirements in more than a dozen practical areas critical to your clinical research programs, including:

State statutory structures for clinical trials

Required notifications to state officials/offices

Legal representative standards

Age of consent/Capacity to consent

Drug dispensing/administration requirements

Informed consent, IRB, and clinical protocol requirements

State licensing authorities (medical, nursing, pharmacy)

Special state rules for cancer research

State HIV testing rules

State requirements for genetic testing

State-specific benefits afforded clinical research
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll